T0682
牛磺猪去氧胆酸钠 水合物
≥98%
别名:
牛磺猪去氧胆酸 钠盐 水合物
登录查看公司和协议定价
关于此项目
线性分子式:
C26H44NO6SNa · xH2O
CAS Number:
分子量:
521.69 (anhydrous basis)
MDL编号:
UNSPSC代码:
12161900
PubChem化学物质编号:
NACRES:
NA.25
描述
anionic
质量水平
方案
≥98%
分子量
521.69 g/mol (anhydrous basis)
应用
detection
SMILES字符串
O.[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
1S/C26H45NO6S.Na.H2O/c1-16(4-7-24(30)27-12-13-34(31,32)33)19-5-6-20-18-15-23(29)22-14-17(28)8-10-26(22,3)21(18)9-11-25(19,20)2;;/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33);;1H2/q;+1;/p-1/t16-,17-,18+,19-,20+,21+,22+,23+,25-,26-;;/m1../s1
InChI key
MJKUJELEPWZEGU-IGEKTTBWSA-M
一般描述
牛磺猪去氧胆酸钠水合物是牛磺酸酰胺化胆盐，可作为阴离子洗涤剂。
应用
牛磺猪去氧胆酸钠水合物已用于一项研究，以评估呋喃处理大鼠肝脏中细胞毒性、再生性细胞增殖和继发性氧化 DNA 损伤的剂量响应数据。 它也被用于一项研究，以探讨使用固定化人工膜 HPLC 柱预测胆盐-膜相互作用。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat.
A Roda et al.
Hepatology (Baltimore, Md.), 27(2), 520-525 (1998-02-14)
The prevention of the hepatotoxic effects produced by intravenous infusion of taurochenodeoxycholic acid (TCDCA) by coinfusion with taurohyodeoxycholic acid (THDCA) was evaluated in bile fistula rats; the hepatoprotective effects of the latter were also compared with those of tauroursodeoxycholic acid
A S Tripodi et al.
Arzneimittel-Forschung, 43(8), 897-903 (1993-08-01)
The mutagenicity of a new biliary acid, taurohyodeoxycholic acid (THDCA, Io, Praxis, CAS 2958-04-5), was assayed by using 5 different tests. The Ames test (reverse mutation assay on Salmonella typhimurium) and the DNA damage and repair test (in Saccharomyces cerevisiae)
F Lanzarotto et al.
Scandinavian journal of gastroenterology, 36(9), 981-986 (2001-08-28)
Tauro-hyodeoxycholic acid is a hydrophilic bile acid of potential interest for treating cholestatic liver diseases. Bile acid pool is enriched with this bile acid during acute administration in patients with interrupted enterohepatic circulation. The aim of our study was to
A S Tripodi et al.
Arzneimittel-Forschung, 43(8), 877-880 (1993-08-01)
In this study we investigated the anticholelithogenic and choleretic activities and the general pharmacological action of taurohyodeoxycholic acid (THDCA, Io, Praxis, CAS 2958-04-5), a new biliary acid advocated for use as anticholelithogenic agent. THDCA had no significant activity on the
P Loria et al.
The Italian journal of gastroenterology, 28(7), 391-392 (1996-09-01)
Taurohyodeoxycholic acid and tauroursodeoxycholic acid were infused intraduodenally at a rate of 0.8 g/h for three hours in 3 cholecystectomized T-tube patients. Biliary lipid secretion and bile acid composition were evaluated before and after replacement of the endogenous bile acid
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持